Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial

PHASE3RecruitingINTERVENTIONAL

Enrollment

338

Participants

Timeline

Start Date

September 4, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

March 30, 2028

Conditions

SurgeryLiver MetastasesLiver CancerPancreas CancerAortic Aneurysm

Interventions

DRUG

Ferric carboxymaltose

Active drug

DRUG

Placebo

Trial Locations (1)

RECRUITING

Uppsala University Hospital, Uppsala

All Listed Sponsors

lead

Jon Unosson

OTHER